Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations...

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Hypoxia-inducible factor-1α (HIF-1α) and p53 are critical in mediating anticancer drug resistance under hypoxic tumor conditions.
• Tumor oxygen levels significantly influence cellular responses to chemotherapy.

Purpose of the Study:

• To investigate the impact of varying hypoxic oxygen concentrations (1% vs. 5% O2) on the cytotoxicity of common anticancer drugs.
• To elucidate the differential roles of HIF-1α and p53 expression in response to these drugs at different oxygen levels.

Main Methods:

• Assessed cytotoxicity of doxorubicin, gemcitabine, and cisplatin on cancer cells at 1% and 5% O2.
• Measured HIF-1α and p53 protein expression levels under drug treatment and varying oxygen conditions.
• Utilized DMOG to stabilize HIF-1α under normoxia and examined p53 response.
• Analyzed the levels of phosphorylated-4E-BP1 as an indicator of HIF-1α translation.

Main Results:

• Anticancer drug cytotoxicity was lower at 1% O2 compared to 5% O2.
• At 5% O2, drugs decreased HIF-1α and increased p53; at 1% O2, drugs increased HIF-1α without altering p53.
• Stabilization of HIF-1α with DMOG blocked drug-induced p53 increases.
• Higher phosphorylated-4E-BP1 levels at 1% O2 suggested increased HIF-1α translation.

Conclusions:

• Tumor cell sensitivity to anticancer drugs is dependent on oxygen concentration under hypoxia.
• The observed resistance at 1% O2 is linked to 4E-BP1-mediated HIF-1α stabilization, which inhibits p53 upregulation.
• Understanding these oxygen-dependent mechanisms is crucial for optimizing cancer therapy.